D-1386-2014 Class II Terminated

Recalled by Actavis Inc — Parsippany, NJ

FDA drug recall D-1386-2014 was initiated by Actavis Inc on May 16, 2014 and is designated Class II. Reason for recall: Subpotent Drug. The recall status is terminated (terminated Feb 23, 2015). Affected quantity: 6913 packages.

Recall details

Product Type
Drugs
Report Date
Jun 25, 2014
Initiation Date
May 16, 2014
Termination Date
Feb 23, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6913 packages

Product description

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

Reason for recall

Subpotent Drug.

Distribution pattern

U.S. Nationwide

Code information

Lot #: 3100135, Expiry: 05/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1386-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1386-2014. Report a data issue: hello@regdatalab.com.